Model Number DTMA1Q1 |
Device Problems
Failure to Deliver Shock/Stimulation (1133); Device Sensing Problem (2917)
|
Patient Problem
Tachycardia (2095)
|
Event Date 03/03/2024 |
Event Type
Injury
|
Manufacturer Narrative
|
Continuation of d10: (b)(6) tissue valve implanted (b)(6) 2016; 694758 lead implanted (b)(6)2012; 5076-52 lead implanted (b)(6) 2008.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
|
Event Description
|
It was reported that the patient was symptomatic.Upon review it was noted that the cardiac resynchronization therapy defibrillator (crt-d) inappropriately withheld therapy for ventricular tachycardia (vt) episodes which were classified as supra ventricular tachycardia (svt) via the device feature that compares the patient¿s current qrs waveform to a collected and stored template of the patient¿s qrs waveform during sinus rhythm.It was also noted that the physician thought the device was classifying episodes as terminated when the events did not appear to be truly terminated clinically. the device is still in use. no further patient complications have been reported as a result of this event.
|
|
Manufacturer Narrative
|
Correction: b2; b5; e1-3; g2; imf (annex f) health impact code.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
|
Event Description
|
It was reported that the patient was symptomatic.Upon review it was noted that the cardiac resynchronization therapy defibrillator (crt-d) inappropriately withheld therapy for ventricular tachycardia (vt) episodes which were classified as supra ventricular tachycardia (svt) via the device feature that compares the patient¿s current qrs waveform to a collected and stored template of the patient¿s qrs waveform during sinus rhythm.It was also noted that the physician thought the device was classifying episodes as terminated when the events did not appear to be truly terminated clinically. the device is still in use. no further patient complications have been reported as a result of this event.It was additionally reported that the device feature was programmed off.
|
|
Search Alerts/Recalls
|